Walmart Inc.

**Signal Note: Driehaus Capital Initiates Walmart Position** This $1.2M Walmart entry by a growth-focused biotech-heavy fund is notable primarily as a portfolio diversification move rather than a biotech-specific catalyst, suggesting potential concern about near-term biotech valuations or sector rotation. The position size (~0.02% of typical biotech allocations) indicates opportunistic positioning in retail/healthcare distribution rather than conviction in a specific therapeutic area or commercial catalyst.